• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

E2F1 介导的 MNX1-AS1-miR-218-5p-SEC61A1 反馈环促进结肠腺癌的进展。

E2F1-mediated MNX1-AS1-miR-218-5p-SEC61A1 feedback loop contributes to the progression of colon adenocarcinoma.

机构信息

The Operating Room, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Nutrition Department, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

出版信息

J Cell Biochem. 2019 Apr;120(4):6145-6153. doi: 10.1002/jcb.27902. Epub 2018 Oct 25.

DOI:10.1002/jcb.27902
PMID:30362161
Abstract

The long noncoding RNA MNX1-AS1 has been reported to facilitate the progression of glioblastoma and ovarian cancer. Nevertheless, the biological roles and underlying mechanisms of MNX1-AS1 in colon adenocarcinoma have not been studied until now. In the current study, MNX1-AS1 was upregulated in colon adenocarcinoma. JASPAR prediction tool showed that E2F1 could bind to the promoter region of MNX1-AS1. The chromatin immunoprecipitation assay and luciferase reporter assay were used to verify the interactions between MNX1-AS1 and E2F1. Then functional assays revealed that downregulation of MNX1-AS1 decreased cell proliferation, migration, and invasion in colon adenocarcinoma, but upregulation of E2F1 reversed the effects. Moreover, subcellular fractionation assay manifested that MNX1-AS1 was enriched in the cytoplasm of colon adenocarcinoma cells, thus we speculated whether MNX1-AS1 could function as a competing endogenous RNA (ceRNA) to play roles in colon adenocarcinoma. Bioinformatics analysis and luciferase reporter assay indicated that MNX1-AS1 could sponge microRNA-218-5p (miR-218-5p). Furthermore, we discovered that SEC61A1 was downstream target of miR-218-5p, and MNX1-AS1 acted as a ceRNA to upregulate the expression of SEC61A1 through sponging miR-218-5p. Finally, rescue assays confirmed that MNX1-AS1 facilitated the progression of colon adenocarcinoma through regulating miR-218-5p/SEC61A1 axis. Taken together, we concluded that E2F1-mediated MNX1-AS1-miR-218-5p-SEC61A1 feedback loop contributed to the progression of colon adenocarcinoma.

摘要

长链非编码 RNA MNX1-AS1 已被报道可促进胶质母细胞瘤和卵巢癌的进展。然而,MNX1-AS1 在结肠腺癌中的生物学作用和潜在机制至今尚未研究。在本研究中,MNX1-AS1 在结肠腺癌中上调。JASPAR 预测工具表明,E2F1 可以结合 MNX1-AS1 的启动子区域。染色质免疫沉淀测定和荧光素酶报告基因测定用于验证 MNX1-AS1 和 E2F1 之间的相互作用。然后,功能测定表明下调 MNX1-AS1 可降低结肠腺癌中的细胞增殖、迁移和侵袭,而上调 E2F1 可逆转这些作用。此外,亚细胞分馏测定表明 MNX1-AS1 富含在结肠腺癌细胞的细胞质中,因此我们推测 MNX1-AS1 是否可以作为竞争性内源 RNA (ceRNA) 在结肠腺癌中发挥作用。生物信息学分析和荧光素酶报告基因测定表明 MNX1-AS1 可以海绵 microRNA-218-5p (miR-218-5p)。此外,我们发现 SEC61A1 是 miR-218-5p 的下游靶标,MNX1-AS1 通过海绵 miR-218-5p 作为 ceRNA 上调 SEC61A1 的表达。最后,挽救测定证实,MNX1-AS1 通过调节 miR-218-5p/SEC61A1 轴促进结肠腺癌的进展。总之,我们得出结论,E2F1 介导的 MNX1-AS1-miR-218-5p-SEC61A1 反馈环促进了结肠腺癌的进展。

相似文献

1
E2F1-mediated MNX1-AS1-miR-218-5p-SEC61A1 feedback loop contributes to the progression of colon adenocarcinoma.E2F1 介导的 MNX1-AS1-miR-218-5p-SEC61A1 反馈环促进结肠腺癌的进展。
J Cell Biochem. 2019 Apr;120(4):6145-6153. doi: 10.1002/jcb.27902. Epub 2018 Oct 25.
2
Long Noncoding RNA MNX1 antisense RNA 1 Exerts Oncogenic Functions in Bladder Cancer by Regulating miR-218-5p/RAB1A Axis.长链非编码 RNA MNX1 反义 RNA 1 通过调控 miR-218-5p/RAB1A 轴在膀胱癌中发挥致癌作用。
J Pharmacol Exp Ther. 2020 Mar;372(3):237-247. doi: 10.1124/jpet.119.262949. Epub 2019 Dec 16.
3
LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis.长链非编码 RNA MNX1-AS1 通过靶向 miR-744-5p/SOX12 轴促进卵巢癌细胞进程。
J Ovarian Res. 2021 Nov 17;14(1):161. doi: 10.1186/s13048-021-00910-0.
4
Long noncoding RNA MNX1-AS1 contributes to lung cancer progression through the miR-527/BRF2 pathway.长链非编码 RNA MNX1-AS1 通过 miR-527/BRF2 通路促进肺癌进展。
J Cell Physiol. 2019 Aug;234(8):13843-13850. doi: 10.1002/jcp.28064. Epub 2019 Jan 7.
5
lncRNA MNX1-AS1 Promotes Glioblastoma Progression Through Inhibition of miR-4443.长链非编码 RNA MNX1-AS1 通过抑制 miR-4443 促进脑胶质母细胞瘤进展。
Oncol Res. 2019 Feb 21;27(3):341-347. doi: 10.3727/096504018X15228909735079. Epub 2018 Apr 20.
6
Long noncoding RNA MNX1-AS1 functions as a competing endogenous RNA to regulate epithelial-mesenchymal transition by sponging MiR-744-5p in colorectal cancer.长链非编码RNA MNX1-AS1作为一种竞争性内源性RNA,通过海绵吸附MiR-744-5p来调控结直肠癌中的上皮-间质转化。
Biosci Biotechnol Biochem. 2021 Feb 24;85(3):568-578. doi: 10.1093/bbb/zbaa096.
7
Long non-coding RNA MNX1-AS1 promotes hepatocellular carcinoma proliferation and invasion through targeting miR-218-5p/COMMD8 axis.长链非编码 RNA MNX1-AS1 通过靶向 miR-218-5p/COMMD8 轴促进肝癌细胞的增殖和侵袭。
Biochem Biophys Res Commun. 2019 Jun 4;513(3):669-674. doi: 10.1016/j.bbrc.2019.04.012. Epub 2019 Apr 11.
8
TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2.TEAD4 调控的长链非编码 RNA MNX1-AS1 部分通过抑制 BTG2 和激活 BCL2 促进胃癌的进展。
Mol Cancer. 2020 Jan 10;19(1):6. doi: 10.1186/s12943-019-1104-1.
9
E2F1-induced upregulation of long non-coding RNA LMCD1-AS1 facilitates cholangiocarcinoma cell progression by regulating miR-345-5p/COL6A3 pathway.E2F1 诱导的长链非编码 RNA LMCD1-AS1 的上调通过调节 miR-345-5p/COL6A3 通路促进胆管癌细胞的进展。
Biochem Biophys Res Commun. 2019 Apr 30;512(2):150-155. doi: 10.1016/j.bbrc.2019.03.054. Epub 2019 Mar 13.
10
Long noncoding RNA FOXD3-AS1 promotes colon adenocarcinoma progression and functions as a competing endogenous RNA to regulate SIRT1 by sponging miR-135a-5p.长链非编码 RNA FOXD3-AS1 通过海绵吸附 miR-135a-5p 促进结肠腺癌进展并作为竞争性内源性 RNA 调节 SIRT1。
J Cell Physiol. 2019 Dec;234(12):21889-21902. doi: 10.1002/jcp.28752. Epub 2019 May 6.

引用本文的文献

1
Integrative Analysis of scRNA-Seq and Bulk RNA-Seq Identifies Plasma Cell Related Genes and Constructs a Prognostic Model for Hepatocellular Carcinoma.单细胞RNA测序与批量RNA测序的综合分析鉴定浆细胞相关基因并构建肝细胞癌预后模型
J Hepatocell Carcinoma. 2025 Feb 26;12:427-444. doi: 10.2147/JHC.S509749. eCollection 2025.
2
Alterations in the expression of serum-derived exosome-enclosed inflammatory microRNAs in Covid-19 patients.新冠病毒肺炎患者血清来源外泌体包裹的炎性微小核糖核酸表达的改变
Heliyon. 2024 Oct 12;10(20):e39303. doi: 10.1016/j.heliyon.2024.e39303. eCollection 2024 Oct 30.
3
MicroRNA-218-5p accelerates malignant behaviors of breast cancer through LRIG1.
miR-218-5p 通过 LRIG1 促进乳腺癌的恶性行为。
Clinics (Sao Paulo). 2023 Oct 28;78:100302. doi: 10.1016/j.clinsp.2023.100302. eCollection 2024.
4
Competitive endogenous RNA networks: Decoding the role of long non-coding RNAs and circular RNAs in colorectal cancer chemoresistance.竞争性内源性 RNA 网络:解析长非编码 RNA 和环状 RNA 在结直肠癌化疗耐药中的作用。
J Cell Mol Med. 2024 Apr;28(7):e18197. doi: 10.1111/jcmm.18197.
5
Systemic analysis of the prognostic significance and interaction network of miR-26b-3p in cholangiocarcinoma.系统分析 miR-26b-3p 在胆管癌中的预后意义及其相互作用网络。
Appl Biochem Biotechnol. 2024 Jul;196(7):4166-4187. doi: 10.1007/s12010-023-04753-x. Epub 2023 Nov 2.
6
A Positive Feedback Loop of E2F4-Mediated Activation of MNX1 Regulates Tumour Progression in Colorectal Cancer.E2F4介导的MNX1激活的正反馈环调节结直肠癌的肿瘤进展
J Cancer. 2023 Sep 4;14(14):2739-2750. doi: 10.7150/jca.86718. eCollection 2023.
7
Prognostic value and chemotherapy response prediction of a proliferation essential gene signature in colon cancer.结肠癌增殖必需基因特征的预后价值和化疗反应预测。
Biosci Rep. 2023 Jul 26;43(7). doi: 10.1042/BSR20230733.
8
Identifying Hub Genes Associated with Neoadjuvant Chemotherapy Resistance in Breast Cancer and Potential Drug Repurposing for the Development of Precision Medicine.鉴定与乳腺癌新辅助化疗耐药相关的枢纽基因,并为精准医学的发展寻找药物再利用的潜力。
Int J Mol Sci. 2022 Oct 20;23(20):12628. doi: 10.3390/ijms232012628.
9
Constructing a prognostic immune-related lncRNA model for colon cancer.构建结肠癌预后免疫相关 lncRNA 模型。
Medicine (Baltimore). 2022 Sep 23;101(38):e30447. doi: 10.1097/MD.0000000000030447.
10
LncRNA MNX1-AS1 contributes to lung adenocarcinoma progression by targeting the miR-34a/SIRT1 axis.长链非编码RNA MNX1-AS1通过靶向miR-34a/SIRT1轴促进肺腺癌进展。
Am J Transl Res. 2022 Jul 15;14(7):4977-4989. eCollection 2022.